Last Updated on September 8, 2021 by The Health Master
Alembic Pharmaceuticals today announced that its joint venture Aleor Dermaceuticals has received final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Metronidazole gel USP, 1%.
In a statement, the company said that the approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Metrogel gel, 1%, of Galderma Laboratories.
Metronidazole gel USP, 1% is indicated for the topical treatment of inflammatory lesions of rosacea.
Aleor had previously received tentative approval for this ANDA, the statement said.
Metronidazole gel USP, 1% has an estimated market size of $29 million for twelve months ending June 2021, according to IQVIA, mentioned the statement.
Dr Reddy’s Labs gets USFDA nod for generic Librax capsules
Granules India gets Health Canada nod for drug for Arthritis pain
Sun Pharma gets exclusive right for Winlevi acne cream in US,…
Aurobindo Pharma gets USFDA nod for cancer treatment drug
USFDA approves drug for severe Itching in kidney disease patients
Zydus Cadila gets USFDA nod for Tofacitinib ER Tablets
Police seized assets of Drug peddler: NDPS Act
5 held for smuggling drugs, huge stock of Tramadol recovered
Safety alert against Hepatitis C drug Sofosbuvir: IPC
NLEM: New list of Essential Medicines: 39 new drugs added, 16…
Govt to include ICD as depot to import Drugs under Drugs…
Latest Notifications regarding Pharmaceuticals
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
